Gilead guts its filgotinib plans, dealing a blow to O'Day's diversification dream | Fierce Pharma
Gilead's Earnings Are Hit by Patent Settlement. The Stock Falls. | Barron's
Why Is Gilead Sciences (GILD) Stock Up Today? | InvestorPlace
Gilead Sciences News, Gilead Sciences Quote, GILD Quote - StreetInsider.com
Gilead Sciences cancer drug hit with partial hold due to adverse event concern - MedCity News
Gilead Sciences wins reversal of $1.2 bln award in patent case with Bristol Myers | Reuters
How Is Gilead (NASDAQ:GILD) Stock Positioned Ahead of ESMO This Week?
Gilead faces criticism for donations to lawmakers who backed 'Don't Say Gay' bill
Stocks making the biggest moves midday: Gilead Sciences, Moderna, Tesla and more
Alabama Doe, et al., v. Gilead Sciences, Inc. - AIDS Law Project
:max_bytes(150000):strip_icc()/gild1-569088a9a3774fe3b8d32167be8698e5.jpg "Gilead Sciences Stock at Cusp of New Uptrend")
Gilead Sciences Stock at Cusp of New Uptrend
Gilead Sciences Stock: Don't Miss The Transformation (NASDAQ:GILD) | Seeking Alpha
Gilead Sciences (@GileadSciences) / Twitter
Coronavirus: Gilead Sciences' upbeat treatment report leads big day on Wall Street
Gilead Sciences 3rd-qtr beats expectations, despite sales and earnings
Gilead sign at headquarters. Gilead Sciences announced plans to test a treatment for COVID-19, disease caused by growing coronavirus outbreak - Foster Stock Photo - Alamy
